Clinical Trial Update: Biomarkers of the Locus Coeruleus Nucleus: Links With Early Tau Pathology, Cognition and Alzheimer's Disease Risk [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update describes studying biomarkers of the locus coeruleus and their links to early tau pathology, cognition, and Alzheimer’s disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: University Hospital, Toulouse | Conditions: Alzheimer Disease | Phase 2 | Status: NOT_YET_RECRUITING